Get the Stockscreener App
329.53
0.92%
-3.1346
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $329.53, with a volume of 118.67K.
It is down -0.92% in the last 24 hours and up +6.56% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$332.66
Open:
$335.27
24h Volume:
118.67K
Relative Volume:
0.18
Market Cap:
$26.74B
Revenue:
$14.14B
Net Income/Loss:
$942.70M
P/E Ratio:
29.20
EPS:
11.2856
Net Cash Flow:
$1.38B
1W Performance:
-2.40%
1M Performance:
+6.56%
6M Performance:
+14.00%
1Y Performance:
+18.56%
1-Day Range:
$329.28
$336.65
1-Week Range:
$329.62
$341.80
52-Week Range:
$244.52
$341.80
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, NTRA, IDXX, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
329.67 | 26.99B | 14.14B | 942.70M | 1.38B | 11.29 |
TMO
Thermo Fisher Scientific Inc
|
606.01 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
210.47 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
319.50 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
547.00 | 43.00B | 4.45B | 1.10B | 1.06B | 13.59 |
IQV
Iqvia Holdings Inc
|
259.50 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Labcorp stock holds near 52-week high as investors weigh recent earnings - Ad-hoc-news.de
Labcorp Declares Quarterly Dividend - Eastern Progress
Madison Asset Management LLC Makes New Investment in Labcorp Holdings Inc. $LH - MarketBeat
20,883 Shares in Labcorp Holdings Inc. $LH Purchased by Great Lakes Advisors LLC - MarketBeat
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health - Sahm
Labcorp Holdings (LH) Could Be 2% Below Fair Value On NACHC Partnership - Sahm
Labcorp director Kerrii B. Anderson sells $954,060 in shares By Investing.com - Investing.com South Africa
Labcorp (NYSE:LH) Director Sells $954,060.00 in Stock - MarketBeat
Labcorp director Kerrii B. Anderson sells $954,060 in shares - Investing.com
Labcorp (NYSE: LH) director sells $954K in preplanned trade - Stock Titan
Labcorp partners with NACHC to develop health center leaders By Investing.com - Investing.com India
Labcorp and a health-center association launch a leadership program as centers serve 52.3 million - Stock Titan
Labcorp (NYSE:LH) Sets New 12-Month HighTime to Buy? - MarketBeat
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
LABCORP HOLDINGS INC. SEC Filing (Aug 17, 2026) - Stock Titan
Labcorp Holdings Sets Investor Day for September 10, 2026, Featuring Executive Strategy Presentations - Kalkine Media
Labcorp to Host Investor Day on September 10, 2026 - The AI Journal
Labcorp Holdings (LH) to Host Investor Day on September 10, 2026 - GuruFocus
Labcorp stock hits all-time high at 325.75 USD - Investing.com
Form 8K Labcorp Holdings Inc For: 17 August By Investing.com - Investing.com Nigeria
Labcorp to hold Investor Day on Sept 10 to disc... - Pluang
Labcorp to host Investor Day Sept. 10 outlining strategy, capital priorities and outlook - TradingView
Labcorp (NYSE: LH) to outline strategy and outlook at Sept. 10 investor day - Stock Titan
Labcorp Holdings Inc. (LH) Stock Analysis: A Healthcare Giant with a 6.17% Upside Potential - DirectorsTalk Interviews
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Labcorp Holdings Inc. $LH - MarketBeat
Insight Inv LLC's Labcorp Holdings Inc(LH) Holding History - GuruFocus
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp Holdings (LH) Announces Leadership Transition in Biophar - GuruFocus
Form 8K Labcorp Holdings Inc For: 14 August By Investing.com - Investing.com Nigeria
Labcorp announces executive leadership changes effective in September - Investing.com
Labcorp Holdings Inc. Announces Executive Changes - marketscreener.com
Labcorp Holdings Inc. (LH) Stock Price, News, Quote & History - ca.finance.yahoo.com
Labcorp CEO Adam H. Schechter Executes Sale of 4,669 Shares via Rule 10b5-1 Plan - Kalkine Media
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million - The Motley Fool
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million - The Motley Fool
Labcorp president & CEO Adam Schechter sells $1.5m in company stock - Investing.com India
Labcorp president & CEO Adam Schechter sells $1.5m in company stock By Investing.com - Investing.com Australia
Insider Selling: Labcorp (NYSE:LH) CEO Sells 4,669 Shares of Stock - MarketBeat
Labcorp Holdings Insider Sold Shares Worth $1,495,808, According to a Recent SEC Filing - marketscreener.com
Labcorp (LH) CEO Adam Schechter sells 4,669 shares at $320.37 under 10b5-1 plan - Stock Titan
Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook? - Yahoo Finance
Labcorp (NYSE:LH) Sets New 52-Week HighStill a Buy? - MarketBeat
Labcorp Holdings Inc. (NYSE:LH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Labcorp Holdings Inc. Stock 12‑Month Price Target Raised to $345.79, Implies 7% Upside - TradingView
Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative? - Yahoo Finance
Adam Schechter (LH) files to sell 4,669 shares of common stock on NYSE - Stock Titan
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich? - The Globe and Mail
Labcorp Wins FDA Approval for Melanoma Companion Diagnostic - marketscreener.com
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):